Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00445458
Status:
COMPLETED
Last Update Posted:
2018-07-26
First Post:
2007-03-08
Brief Title:
A Phase 12 Study of HKI-272 Neratinib in Combination With Paclitaxel Taxol in Subjects With Solid Tumors and Breast Cancer
Sponsor:
Puma Biotechnology Inc
Organization:
Puma Biotechnology Inc
Organization Data
Organization:
Puma Biotechnology Inc
Class:
INDUSTRY
Study ID:
3144A1-203 B1891014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Puma Biotechnology Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None